Gilead Sciences, Inc. v. Apotex Inc. et al
| Gilead Sciences, Inc. |
| Apotex Inc., Apotex Corp., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc. |
| 1:2023cv00774 |
| July 14, 2023 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 14, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 13
SO ORDERED re (151 in 1:21-cv-01621-MN, 12 in 1:23-cv-00774-MN) Stipulation and Order of Infringement and Consolidation. Signed by Judge Maryellen Noreika on 8/14/2023. (dlw)
|
| Case associated with lead case: Create association to 1:21-cv-01621-MN. (dlw) |
| Filing 12 STIPULATION of Infringement and Consolidation and [Proposed] Order by Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) |
| Filing 11 WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For MSN Pharmaceuticals Inc. waiver sent on 7/24/2023, answer due 9/22/2023. (Tigan, Jeremy) |
| Filing 10 WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For MSN Life Sciences Private Ltd. waiver sent on 7/24/2023, answer due 9/22/2023. (Tigan, Jeremy) |
| Filing 9 WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For MSN Laboratories Private Ltd. waiver sent on 7/24/2023, answer due 9/22/2023. (Tigan, Jeremy) |
| Filing 8 WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For Apotex Inc. waiver sent on 7/18/2023, answer due 9/18/2023. (Tigan, Jeremy) |
| Filing 7 WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For Apotex Corp. waiver sent on 7/18/2023, answer due 9/18/2023. (Tigan, Jeremy) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:23-cv-00774-MN, 1:23-cv-00775-MN (rjb) |
| Filing 6 Summonses Issued as to Apotex Corp., Apotex Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals Inc. on 7/14/2023. (Attachments: #1 Summons Issued Apotex Inc., #2 Summons Issued MSN Laboratories Private Limited, #3 Summons Issued MSN Life Sciences Private Ltd., #4 Summons Issued MSN Pharmaceuticals Inc.)(jfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc. (jfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,039,718 B2. (jfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 2, 2023. Date of Expiration of Patent: October 6, 2032 & April 6, 2033 with PED. Thirty Month Stay Deadline: 12/2/2025. |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
| Filing 1 COMPLAINT filed against Apotex Corp., Apotex Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc. (Filing fee $ 402, receipt number ADEDC-4179384.) - filed by Gilead Sciences, Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(jfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
